NCT02928978
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02928978
Title Ruxolitinib for Premalignant Breast Disease
Acronym TBCRC042
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Julie Nangia
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.